Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the safety and tolerability of open-label treatment with licarbazepine 750-2000 mg/d over 52 weeks in patients who completed the 6-week double-blind study CLIC477D2303, with respect to the rates of adverse events and serious adverse events, as well as changes in laboratory values, ECGs and vital signs.
Inclusion criteria
- Bipolar I disorder, manic and mixed episodes